Current results of open surgical repair of descending thoracic aortic aneurysms  by Black, James H. & Cambria, Richard P.
Chapter 2
Current results of open surgical repair
of descending thoracic aortic aneurysms
James H. Black, III, MD,a and Richard P. Cambria, MD,b Baltimore, Md; and Boston, MassINTRODUCTION
Descending thoracic aortic aneurysms (TAAs) are esti-
mated to affect 10 of every 10,000 elderly adults, with 30%
to 40% of these aneurysms being limited to the thoracic
aorta.1 Although traditionally viewed as less threatening
and less demanding from a technical standpoint than the
more extensive thoracoabdominal aneurysms, TAA repair
presents the surgeon with a multitude of technical and
cognitive challenges that extend through the perioperative
period. Improvements in operative care, particularly an
aggressive posture toward intercostals preservation and the
adoption of protective adjuncts against spinal cord ischemic
complications,2-6 have halved the overall incidence of spi-
nal cord ischemia (SCI) since the Crawford et al bench-
mark7 series describing a 16% incidence of SCI in 1500
patients. Contemporary reports from centers of excellence
detail a consistent overall 5% to 10% risk of SCI.7-11 Despite
considerable progress, no single operative strategy to date
has been totally effective in eliminating the problem of SCI
and the resultant substantial morbidity that follows TAA
repair.
Juvonen et al12 reported on 114 patients with thoraco-
abdominal aortic aneurysms (TAAAs) managed without
surgery and followed over a mean interval of 28 months.
Most of the study population did not have large extent
TAAAs, but because the threshold for surgery was main-
tained at 7 cm, the data have important implications. An-
eurysm rupture occurred in 23% of their patients, and
another 20% had compelling indications for operation,
such as pain and leak. Relatively modest mean diameters of
5.8 cm were appreciated in the ruptured thoracic aneurysm
patients, and on analysis, pain and chronic obstructive
pulmonary disease were associated with an elevated risk of
rupture. Given the significant rupture rates with a treat-
ment threshold of 7 cm, this diameter is likely too conser-
vative. In a separate study, the natural history of TAA
dictated a 30% 5-year risk of rupture when a TAA is6 cm,
and thus the general recommendation of 6 cm as an appro-
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6Apriate size for repair seems warranted in acceptable-risk
patients.13
Despite the variety of operative approaches used in the
treatment of TAA, consistent themes with regard to the
clinical variables influence both the overall risk of TAA
operation and the risk of cord injury. Balancing these risks
represents a clinical dilemma for the aortic surgeon, and a
thoughtful, logical risk analysis of the individual patient
presentation is clearly warranted before repair of TAA.
Regarding operative risk, mortality in circumstances other
than elective operation is essentially doubled.4,9 Interest-
ingly, the explanation for this is not so simple as hemody-
namic instability, as most patients are stable during their
preoperative preparation. Regardless, the association of
nonelective operation and perioperative mortality has been
verified in many series.3,4,9
Renal failure, whether dialysis-dependent or not, has
been consistently noted as a predictor of early death.3,4,9
Advanced age has also been associated with adverse out-
comes in TAA.3,9,14 In our view, the patient’s overall
functional status appears to be more important than the
chronologic age. In support, Huynh et al15 recently re-
ported acceptable perioperative mortality in 63 octogenar-
ians who underwent TAA repair. The perception of unac-
ceptable risk leading to denial of open treatment has, in
part, driven the demand for further refinement of surgical
technique and alternative therapies for TAA such as endo-
vascular repair.
In this chapter, we review the surgical approaches to
TAA and adjunctive methods to decrease end-organ injury
and SCI, and examine retrospective reviews of the results of
TAA in centers of excellence. Population-based reviews
highlight the functional outcomes in broader national sam-
ples of TAA, and lastly, new data from prospective registries
elucidate the challenges yet to be overcome in the manage-
ment of patients with aneurysms of the descending thoracic
aorta.
OPERATIVE STRATEGY
In general, strategies to decrease the incidence and
severity of end-organ injury and SCI after TAA repair have
fallen into two categories. Strategies in the first category are
aimed at maintaining visceral and spinal cord blood supply
during the course of the operation and include both shunts
and bypasses for distal aortic perfusion, preoperative iden-
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drainage, and reconstruction of intercostal arteries.16
The basic premise for distal aortic perfusion is the
ability to maintain blood flow to visceral and spinal aortic
branch vessels, usually accomplished via partial left heart
bypass (LHB) (Fig 1). Clearly, the efficacy of distal aortic
perfusion is a function of TAA extent. Those lesions truly
isolated to the descending thoracic aorta are clearly amena-
ble to continuous distal perfusion throughout the cross-
clamp interval, whereas those lesions that involve the vis-
ceral segment, or portions thereof, disallow the same unless
a scheme of “octopus” catheters is used. The balance of
femoral inflow and the visceral octopus perfusion catheter
inflow may invite problematic pressure/volume relation-
ships. Full cardiopulmonary bypass involves significant in-
creases in need for heparinization and the threat of signifi-
cant blood turnover. LHB via a centrifugal pump carries
the advantage of less need for anticoagulation as well as the
ability to control distal perfusion pressure.
The second general category consists of a wide variety
of neuroprotective adjuncts, either pharmacologic agents
or variations of hypothermic adjuncts, to attenuate excita-
tory and inflammatory mechanisms that contribute to the
ischemic injury. As shown in clinical reports, specific phar-
macologic inhibitors (eg, naloxone) of excitatory neuro-
transmission decrease spinal cord metabolism.14
Hypothermia may appear to be a nonspecific means of
decreasing spinal cord metabolic demand; however, the
Fig 1. Open thoracic aneurysm repair accomplished with left
heart bypass via left atrial cannula and femoral inflow (preferred
approach at Johns Hopkins Hospital). This approach entails pos-
terolateral thoracotomy to achieve surgical exposure. Clamp-and-
sew is also a viable alternative if lesion extent or complexity is
moderate. (Reprinted from Willams GM and Schlossberg L. Atlas
of aortic surgery. Baltimore, Md: Williams and Wilkins, 1997.)mechanism may involve a complex interplay of neuronalmembrane stabilization, reduced neurotransmission, and
decreased oxygen requirement. Beginning in 1993, we
have used regional hypothermia with epidural cooling (via
an intrathecal catheter) in patients with types I, II, and III
TAAs. Our initial experience with 70 patients was com-
pared with 55 historical controls. In this first series, lower-
extremity neurologic deficit was significantly reduced in the
group treated with adjunctive epidural cooling.3,17
The approach to TAA repair at the Massachusetts Gen-
eral Hospital has emphasized expeditious restoration of
intercostal blood flow in the critical zone of T9 to L1,
combined with regional hypothermia of the spinal cord
accomplished with epidural cooling, and passive postoper-
ative cerebrospinal fluid drainage.17 LHB is used on a
highly selective basis and may be preferred in scenarios of
increasing proximal anastomotic complexity (eg, aortic dis-
section) or in extent I/II TAAA.
RETROSPECTIVE REVIEW OF RESULTS
IN CENTERS OF EXCELLENCE
Several large retrospective series of isolated TAA repair
(not TAAA) are summarized in Table I. These published
series reflect state-of-the-art results and demonstrate an
admirable incidence of perioperative major morbidity (re-
nal failure and paraplegia) and mortality.18-21
In the series of Coselli et al,18 their retrospective review
compared outcomes of all patients with TAA repaired by
use of LHB or by clamp-and-sew techniques. Using pro-
pensity scoring and risk stratification analysis, they could
not prove that routine use of LHB was more protective
against paraplegia than the shorter clamp time and less
transfusion-prone clamp-and-sew technique. By this statis-
tical analysis, it would appear LHB and clamp-and-sew
techniques can provide equivalent outcomes and both are
acceptable operative strategies.18
In the review by Estrera et al, the authors examined
those patients with nonemergent (elective) operations.19
In the 105 patients with nonemergent presentations re-
paired with LHB and cerebrospinal fluid drainage, early
neurologic deficits occurred in only 1 patient (0.9%) vs 3
(7.0%) of 43 nonemergent patients repaired without those
same adjuncts (P  .04).19 Clearly, these results confirm
the ability to reduce the incidence of SCI in the controlled
situation of adjunctive methods applied to elective repairs.
Similarly, in the report from Galloway et al,20 the
authors detail the risk of death and paraplegia in TAA repair
as being related primarily to emergent presentation and not
operative technique. Paraplegia occurred in none (0 of 62)
their elective TAA patients but in 18.6% of their emergent
TAA patients. The operative mortality was markedly ele-
vated by acute presentation (25% vs 6.5% in elective re-
pair).20 The association of emergent presentation and
worsened outcomes (pulmonary/SCI/renal impairment)
has been confirmed in a large review of 112 patients with
acute TAAA by LeMaire et al,22 as well as others.4,10 Using
a technique of passive distal perfusion with a 9-mm Gott
shunt, Verdant et al21 reported no cases of postoperative
SCI events, a result not subsequently reproduced by other
clamp
JOURNAL OF VASCULAR SURGERY
February Supplement 20068A Black and Cambriagroups. As a possible explanation, the authors highlighted
the limited extent of TAA replacement in their series, with
335 (91.5%) of 366 patients undergoing replacement of
one third or less of total thoracic aortic length.21 In addi-
tion, these limited resections involved few emergent pa-
tients, and aortic cross-clamp time averaged 30 minutes
(range, 8 to 124 minutes).20 In light of all the aforemen-
tioned studies, it is likely that emergent presentations will
continue to predict major complications and death, even in
experienced hands.
In summary, acceptable outcomes can be achieved
through a variety of operative strategies. Surgeon and
hospital-related experience (ie, yearly case volume) may be
quite important in attempting to extrapolate the exceed-
ingly low incidence of complications and death from the
best reports to the daily practice of TAA repair across the
United States.
POPULATION-BASED STUDIES
OF OUTCOMES OF TAAA REPAIR
As mentioned, TAAA repair presents a greater threat of
renovisceral and spinal complications than TAA repair as a
function of the extent of aortic replacement. Yet a look into
the broader sample of repaired TAAA patients in state- and
nationwide databases reveals the sobering real-life results of
the surgical practice of complex aneurysm repair in the last
decade.
The incidence of death after TAAA repair may not be
captured by a 30-day mortality statistic. In an age-stratified
study by Rigberg et al23 of patients who underwent repair
of an intact TAAA, statewide 30-day mortality statistics
consistently underestimated 1-year survival across age
groups. In the 640 total patients who underwent TAAA
repair, overall mortality at 1-year was 32% vs only 20%
reported in the first 30 days postoperatively.23 The effect
was more pronounced in octogenarians, with 28% dying
30 days of TAAA repair and 44% by 1 year.23 The authors
hypothesized that cardiovascular mortality or other causes
continue to claim patients for months after the original
operations, and that this is not properly estimated and
captured by the accepted reporting standards.23
The University of Michigan group identified greater
hospital and surgeon volumes as contributing to improved
outcomes in TAAA.24 With 1542 patients, the National
Inpatient Sample (NIS) from 1988 to 1998 represents
Table I. Results of open thoracic aneurysm repair
Author, year Patients (N) Elective/urgent (%)
Coselli,18 2004 387 329/58 (17) 
Estrera,19 2001 182 182/34 (18) 
Galloway,20 1996 78 78/16 (20) 
Verdant,21 1995 366 351/15 (4) 
*Adjunctive techniques: LHB, left heart bypass with distal perfusion; C&S,
shunt for distal perfusion; jAAA, juxtarenal AAA.approximately 20% of US hospitals. Within this group,overall mortality for TAAA repair was 22.3%, but did
improve over time.24 Significantly, operative mortality was
25.6% for low-volume surgeons vs 11.0% for high-volume
surgeons (P  .001).24 Length of stay, mortality, and
cardiopulmonary complications were likewise correlated
with higher-volume hospitals and surgeons. The authors
champion regionalization as a method to improve delivery
of care to patients with complex aneurysms.24
Given the soberingmortality data reportedbypopulation-
based studies, the findings of the Rectenwald et al25 further
indicate the need to re-examine the contemporary results of
TAAA repair. From their academic medical center, 101
consecutive TAAA patients, including 58 elective repairs
and 43 emergent repairs, were reviewed for outcomes at 1
year. A “good” outcome meant being ambulatory or sur-
viving to home or to a rehabilitation hospital; “bad” out-
comes included death, discharge to a long-term facility, or
being nonambulatory.25 Again, immediate results demon-
strated a high overall mortality of 17.8%, with a mean
length of stay of 22.8  23.6 days.25 By 1 year, overall
survival was only 67%, with barely more than 50% of
patients recording a good outcome. Bad outcomes were
predicted by age 75 years, duration of visceral ischemia,
LHB, and renal dysfunction.25 Eliminating patients with
acute presentations raised the good outcomes in the elec-
tive subset to 63%. The authors concluded that good
outcomes after TAAA repair are significantly less common
than acknowledged in the literature and hypothesized that
refinement of operative strategy may be needed.25
As a function of a less extensive replacement, TAA
repair likely poses less of a perioperative threat than TAAA
repair. Nonetheless, the clinical imperative of TAA repair
assumes that the risk of operative complications and bad
outcomes is outweighed by the aneurysm threat detailed by
natural history studies. Yet if the aforementioned TAAA
population studies can be extrapolated to TAAs, one may
conjecture that even in academic centers across the United
States, there is ample opportunity to refine technique and
re-examine our risk assessments of TAA repair.
RECENT DATA FROM PROSPECTIVE STUDIES
Randomization of patients with TAA to open or endo-
vascular repair has not been performed to date. However,
comparative data from prospective studies of endovascular




failure (%) Paraplegia (%) Technique*
2.8 7.4 2.6 LHB, C&S
8.8 NA 2.7 LHB, CSFD
10.3 NA 3.8 LHB, C&S
12 2.4 0 Gott
-and-sew technique; CSFD, cerebrospinal fluid drainage; Gott, 9-mm Gott3
morporary results of surgical practice than can be obtained from
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ing and reporting errors.
In a study from theMassachusetts General Hospital, 81
patients who underwent stent-graft repair were compared
with a concurrent group of 91 patients undergoing open
repair of TAA (n  37) or type I TAAA (n   54).26
Perioperative mortality in the open cohort (no ruptured
TAAs included) was 13.1% vs 8.9% in the stent-graft co-
hort. Interestingly, in contradistinction to conventional
wisdom, paraplegia and paraparesis rates were similar in
both groups: 4.5% open and 4.9% stent-graft. Although
stent-graft repair was associated with improved early sur-
vival, by a mean follow-up of 54 months, the actuarial
survival of both cohorts was similar.26
The recently presented phase II study of a thoracic
aortic stent-graft approved by the US Food and Drug
Administration shed some light on the real-world results of
TAA repair. In a cohort-controlled study of 94 patients
who underwent open TAA repair, patients were monitored
for postoperative events and followed for 2 years for late
events such as aortic complications, reinterventions, and
survival.27 The results of a group of 140 patients undergo-
ing endovascular thoracic aneurysm repair served as the
comparison cohort.28 Seventeen academic centers across the
United States participated in the enrollment from 1998 to
2001.
Surgical technique for thoracic aortic replacement in-
cluded extracorporeal support in 78% patients; spinal drain-
age was not consistently used.24 Mean age, aortic morphol-
ogy, and past medical history were all similar between
endovascular and open TAA groups. The 30-day mortality
was 11.7% in the open TAA “controls” vs 2.1% in the
endovascular group. Paraplegia/paraparesis was encoun-
tered in 13.8% of the open TAA patients vs 3% of those
undergoing endovascular repair. Renal failure was noted in
12% and respiratory failure (24 hours mechanical ventila-
tion or reintubation) in 20% of open TAA patients vs 1%
and 4% in the endovascular group. The authors noted the
13.8% of spinal ischemia was significantly higher than ap-
preciated in the “best” series, and pointed to variable
surgeon experience, variable hospital volume, and variable
cerebrospinal fluid drainage as likely responsible for the
untoward results of open TAA.27 This series represents
Table II. Results of “hybrid” thoracoabdominal aortic an
Author, year Patient (N) Extent (N)
F/U
(months)
Flye,29 2004 3 III, IV, patch 11-21 
Fulton,30 2005 10 IV(2) 0-13 
jAAA(8)




TIA, Transient ischemic attack; CV, cardiovascular; GI, gastrointestinal.perhaps the best assessment available of comparative real-world results of open TAA vs stent-graft repair in the
nation.
FUTURE DIRECTIONS IN TAA
AND TAAA REPAIR
It is clear that impressive reductions in morbidity and
mortality have been realized in the arena of complex
aneurysm repair, especially in centers of excellence.
However, diffusion and adoption of open surgical tech-
niques of TAAA repair across centers has been diffi-
cult and may indicate that less stellar results are the
norm. Indeed, audited data in the United Kingdom
Cardiac Surgical Register, presented by Black et al,29
revealed mortality for replacement of the descending
thoracic aorta approaching 34%. The application of
stent-graft repair to the more complex TAAAs has been
limited by the origin of the visceral vessels off the aneu-
rysm itself.
Single-center reports are now emerging which detail
open techniques to ensure end-organ perfusion via surgical
bypasses and subsequent stent-graft coverage of significant
lengths of thoracovisceral aorta. The results of these studies
are summarized in Table II.29-31
A key tenet of the surgical aspects of the “hybrid”
exclusions is the performance of individual bypasses to the
visceral branches with ligation of the origins to prevent type
II endoleak (Figs 2 and 3); in either the same procedure as
the surgical revascularization or in a staged fashion days
later, the endograft is inserted to cover the aneurysmal
thoracovisceral aorta. In endovascular exclusion, proper
fixation zones and substantial overlap of endoprostheses are
mandatory to withstand the substantial hemodynamic
forces present. In the series of Flye et al29 and Black et al31
it was not uncommon for four to seven pieces to be placed
in a single patient. Although the occurrence of more type I
and III endoleaks can be expected in such cases, most of
them would seem to be correctable with secondary, “non-
surgical” endovascular procedures. Clearly, long-term data
regarding this very creative approach to extensive TAAAs
are lacking, yet the complication rates (particularly SCI,
paraplegia, and paraparesis) compare favorably with series
m revascularization and endovascular repair
-day
rtality
Type I or III
leak (%) Complication (N) Paraplegia (%)
0 33 (III) TIA (1) 0
0 10 (I) CV (2); Pulm (2) 0
GI (1)
5% 23 (I) CV (7); Pulm (9) 0
4 (III) Renal 4; GI (3)eurys
30
mo
1detailing open TAAA repair.6-11
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Open surgical repair of TAA is known to be durable
with a low incidence of secondary aortic interventions.
Fig 2. Angiogram of completed “hybrid.” Bypass grafts are evi-
dent to left renal artery and superior mesenteric artery via a single
limb and separate limb to hepatic and right renal arteries. (Cour-
tesy Patrick Geraghty, Washington University School of Medi-
cine.)
Fig 3. Computed tomography angiography of completed “de-
branching” of the aortic arch to facilitate stent-graft repair of distal
arch aneurysm.Graft-related complications per se, such as infection oranastomotic aneurysm, are very rare; secondary interven-
tions occur in approximately 10% of patients and are usually
located in noncontiguous aortic segments.32 Although
considerable progress has been made in diminishing the
incidence and severity of postoperative renovisceral and
spinal complications, no strategy to date has eliminated
them. Based on single-center retrospective reviews and
population data, acute presentations of TAA portend ardu-
ous postoperative courses and adversely impact long-term
functional outcomes. Surgeon-related case volumes may
also merit examination and motivate regionalization of
complex aneurysm surgery to improve outcomes.
As comparative studies of open TAA repair and stent-
graft repair emerge, endovascular repair will likely continue
to demonstrate impressive reductions in overall periopera-
tive morbidity and mortality, albeit with an assumed in-
crease in the need for secondary aortic interventions. How-
ever, for some patients with more extensive aneurysms who
are at high risk for complications, variations in open surgical
techniques to maintain end-organ perfusion and achieve
“hybrid” endovascular reconstruction of TAA and TAAA
are more likely to become complementary and not mutu-
ally exclusive.
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